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abstract
 
We investigated the effect of protein kinase A (PKA) on passive force in skinned cardiac tissues that
express different isoforms of titin, i.e., stiff (N2B) and more compliant (N2BA) titins, at different levels. We used
rat ventricular (RV), bovine left ventricular (BLV), and bovine left atrial (BLA) muscles (passive force: RV 
 
 
 
 BLV 
 
 
 
BLA, with the ratio of N2B to N2BA titin, 
 
 
 
90:10, 
 
 
 
40:60, and 
 
 
 
10:90%, respectively) and found that N2B and
N2BA isoforms can both be phosphorylated by PKA. Under the relaxed condition, sarcomere length was increased
and then held constant for 30 min and the peak passive force, stress-relaxation, and steady-state passive force were
determined. Following PKA treatment, passive force was signiﬁcantly decreased in all muscle types with the effect
greatest in RV, lowest in BLA, and intermediate in BLV. Fitting the stress-relaxation data to the sum of three
exponential decay functions revealed that PKA blunts the magnitude of stress-relaxation and accelerates its time
constants. To investigate whether or not PKA-induced decreases in passive force result from possible alteration of
titin–thin ﬁlament interaction (e.g., via troponin I phosphorylation), we conducted the same experiments using
RV preparations that had been treated with gelsolin to extract thin ﬁlaments. PKA decreased passive force in
gelsolin-treated RV preparations with a magnitude similar to that observed in control preparations. PKA was also
found to decrease restoring force in skinned ventricular myocytes of the rat that had been shortened to below the
slack length. Finally, we investigated the effect of the 
 
 
 
-adrenergic receptor agonist isoprenaline on diastolic force
in intact rat ventricular trabeculae. We found that isoprenaline phosphorylated titin and that it reduced diastolic
force to a degree similar to that found in skinned RV preparations. Taken together, these results suggest that during
 
 
 
-adrenergic stimulation, PKA increases ventricular compliance in a titin isoform-dependent manner.
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INTRODUCTION
 
 
 
-Adrenergic stimulation activates PKA in cardiac
muscle, resulting in phosphorylation of a number of
proteins, including L-type Ca
 
2
 
 
 
 channels, ryanodine
receptors, phospholamban, troponin I (TnI), and my-
osin-binding protein C (My-BPC) (for a recent review
with original citations see Bers, 2001, 2002). Accordingly,
myocardial function is associated with increased de-
veloped force and increased rates of rise and fall of
developed force. Changes in intracellular Ca
 
2
 
 
 
 handling
are generally thought to be important for these effects
(Kurihara and Konishi, 1987; Endoh and Blinks, 1988;
Li et al., 2000; Bers, 2001, 2002). However, accumulating
evidence suggests that myocardial properties are modu-
lated, at least in part, at the myoﬁlament level following
 
 
 
-adrenergic stimulation, by accelerating crossbridge
cycling (Hoh et al., 1988; Hongo et al., 1993; Kentish et
al., 2001), enhancing power output (Herron et al., 2001;
Layland and Kentish, 2002) and facilitating dissociation
of Ca
 
2
 
 
 
 from troponin C (TnC) via phosphorylation of
TnI (Robertson et al., 1982; Zhang et al., 1995), resulting
in decreased Ca
 
2
 
 
 
 sensitivity of force (Garvey et al., 1988;
Wattanapermpool et al., 1995; Fentzke et al., 1999).
In striated muscle, titin functions as a molecular
spring that is responsible for most passive stiffness
within the physiological sarcomere length (SL) range
(Granzier and Labeit, 2002). Titin also plays a role as a
molecular scaffold in the sarcomere (Gregorio et al.,
1999) and was recently proposed to be a factor in the
Frank-Starling mechanism of the heart because it pro-
motes actomyosin interaction in response to stretch
(Fukuda and Granzier, 2004). In the mammalian heart,
titin exists in two isoforms with different molecular
lengths, i.e., the shorter N2B isoform (high passive
force) and longer N2BA isoform (low passive force)
(Granzier and Labeit, 2002).
Recently, we reported that titin’s unique cardiac-spe-
ciﬁc N2B segment is phosphorylated by PKA, resulting
in a reduction of passive force in rat cardiomyocytes in
response to stretch (Yamasaki et al., 2002). To understand
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the physiological role of titin phosphorylation in the
heart’s diastolic function, we investigated the effects of
PKA on passive properties of myocardial tissues with
different passive stiffness resulting from differential
titin expression proﬁles. It is important to note that the
expression ratio of N2B titin to N2BA titin markedly
varies in a species-speciﬁc and chamber-speciﬁc man-
ner, with an 
 
 
 
50:50 ratio occurring in the ventricles
of large mammals, including humans (Cazorla et al.,
2000). Furthermore, adjustments in the coexpression
ratio take place in patients with coronary artery disease
or dilated cardiomyopathy (Wu et al., 2002; Neagoe et
al., 2002; Makarenko et al., 2004; Nagueh et al., 2004).
It is important to know therefore whether or not N2BA
titin is phosphorylated as shown for N2B titin (Yama-
saki et al., 2002), and if so, to what extent passive prop-
erties are modulated by PKA in myocardial tissues with
different titin expression proﬁles.
Results show that PKA phosphorylates both N2B and
N2BA titins, resulting in decreases in passive force, with
greater effects in muscles that express N2B titin at
higher levels. Furthermore, the PKA-induced decrease
in passive force is seen in muscles from which thin ﬁla-
ments are extracted by gelsolin, and our results reveal
that titin is phosphorylated and diastolic force is re-
duced in intact cardiac muscle in response to 
 
 
 
-adren-
ergic stimulation.
 
MATERIALS AND METHODS
 
All experiments were conducted in accordance with the Guide
for the Care and Use of Laboratory Animals (National Academy
of Sciences, Washington D.C., 1996).
 
Skinned Muscle Preparation
 
Skinned muscles were prepared based on previously published
procedures (bovine muscle, Wu et al., 2000 and Fukuda et al.,
2003; rat muscle, Fukuda et al., 2000, 2005).
Myocardium from the left ventricle and left atrium of the adult
cow (
 
 
 
1.5 yr) was cut into small pieces and placed into a modi-
ﬁed Krebs solution (see Wu et al., 2000 for exact composition;
containing 30 mM 2,3-butanedione monoxime [BDM] to inhibit
actomyosin interaction) with propranolol (10 
 
 
 
M) to block non-
speciﬁc 
 
 
 
-adrenergic stimulation and with carbamyl choline (10
 
 
 
M) to enhance phosphatase activity (Gupta et al., 1994). BDM
is also known to enhance dephosphorylatoin of myoﬁbrillar pro-
teins (Venema et al., 1993; Turnbull et al., 2002) and may thus in-
crease the likelihood that titin is in a dephosphorylated state.
The presence of propranolol, carbamyl choline, and BDM, how-
ever, does not exclude basal levels of protein phosphorylation.
Muscle strips (diameter, 1–2 mm; length, 
 
 
 
10 mm) were next
dissected and skinned in relaxing solution (5 mM MgATP, 40
mM BES, 1 mM Mg
 
2
 
 
 
, 10 mM EGTA, 1 mM dithiothreitol, 15 mM
phosphocreatine, 15 U/ml creatine phosphokinase, 180 mM
ionic strength [adjusted by K-propionate], pH 7.0) containing
1% (wt/vol) Triton X-100 overnight at 
 
 
 
3
 
 
 
C. Muscles were then
washed with relaxing solution and stored (for 1 mo or less) at
 
 
 
20
 
 
 
C in relaxing solution containing 50% (vol/vol) glycerol.
Small preparations (100–200 
 
 
 
m in diameter; 
 
 
 
2 mm in length)
were dissected from these strips for force measurement.
The heart was quickly removed from male LBNF-1 rats (200–
250 g) anesthetized with sodium pentobarbital (50 mg/kg, IP)
and perfused through the aorta with the Krebs solution (see
above). Thin trabeculae (100–200 
 
 
 
m in diameter; 1–2 mm in
length) were then dissected from the right ventricle and skinned
for 2 h in relaxing solution containing 1% Triton X-100 at 
 
 
 
3
 
 
 
C.
Muscles were then washed with relaxing solution, stored over-
night at 
 
 
 
3
 
 
 
C in relaxing solution, and used in the following day.
To prevent protein degradation, all solutions used in the present
study contained protease inhibitors (PMSF, 0.5 mM; leupeptin,
0.04 mM; E64, 0.01 mM).
 
Skinned Muscle Mechanics
 
First, we activated the preparation at the slack SL (SL 1.90 
 
 
 
m)
with a saturating Ca
 
2
 
 
 
 concentration (pCa 4.5) to secure the ends
of the preparation and to determine the quality of the contractile
machinery. The values of maximal Ca
 
2
 
 
 
-activated force (see be-
low) were similar to those obtained in our previous studies con-
ducted under the same experimental condition (Fukuda et al.,
2003, 2005). The preparation was stretched from the slack SL (i.e.,
1.90 
 
 
 
m) to various SLs at a constant velocity of 0.1 muscle
length/s and held for 30 min (15 min for gelsolin experiments;
see Fig. 5), followed by a release to the slack SL (SL measured by
later diffraction, Granzier and Irving, 1995; Wu et al., 2000;
Fukuda et al., 2003, 2005). After 1 h, the preparation was stretched
again at the same velocity to determine the reproducibility of pas-
sive force. Only when the passive force development was repro-
ducible (
 
 
 
3% reduction; used as a criterion), the preparation was
incubated for 50 min at 22
 
 
 
C with puriﬁed PKA (catalytic subunit
from bovine heart; Sigma-Aldrich) at a concentration of 1 U/
 
 
 
l,
based on our previous study (Yamasaki et al., 2002). In some ex-
periments, we used PKA-speciﬁc inhibitor (PKI; Sigma-Aldrich) at
a concentration of 50 
 
 
 
M. Then, the same stretch-hold protocol
was repeated and stress-relaxation data were obtained.
Finally, according to previous reports (Granzier and Irving,
1995; Wu et al., 2000; Fukuda et al., 2003, 2005), the preparation
was treated with KCl/KI, and titin-based passive force was ob-
tained as total passive force minus collagen-based (KCl/KI insen-
sitive) passive force. We found in collagen strips (prepared from
rat ventricular trabeculae with KCl/KI treatment) that passive
force is unaffected by PKA treatment (not depicted). Through-
out the study, to minimize contraction-induced structural dam-
age on the preparation and to ensure high reproducibility of pas-
sive force (Fukuda et al., 2003, 2005), we measured passive and
active forces at 12
 
 
 
C.
To extract thin ﬁlaments, some rat ventricular (RV) prepara-
tions were incubated overnight at 
 
 
 
4
 
 
 
C in relaxing solution con-
taining gelsolin fragment FX-45 (
 
 
 
1 mg/ml) during continuous
agitation. Maximal Ca
 
2
 
 
 
-activated force was decreased to 
 
 
 
5% of
the control value with no signiﬁcant difference in the value of
steady-state passive force (see below). To ensure high reproduc-
ibility of passive force, we tested the effect of PKA on passive force
(as described above), using a shorter (i.e., 15 min) hold period.
 
Restoring Force Measurement
 
Myocytes were enzymatically isolated from the hearts of male
Wistar rats (200–250 g) and anesthetized with sodium pentobar-
bital (50 mg/kg, IP) as described in our previous study (Granzier
and Irving, 1995). The myocytes were skinned with relaxing solu-
tion (see above) containing 0.3% (wt/vol) Triton X-100 for 50
min at room temperature (22
 
 
 
C) (Granzier and Irving, 1995).
We measured relengthening velocity of skinned cardiomyocytes
following rigor contraction, as a surrogate of restoring force,
using methods based on the work by Sawyer and colleagues
(Helmes et al., 2003). In brief, a single myocyte was perfused us- 
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ing a multibarrel pipette perfusion setup with a fast-step switcher
(SF-77B; Warner Instruments Corporation). The multibarrel pi-
pette was attached to a stepper motor that could rapidly switch
the adjacent barrel (barrel diameter 800 
 
 
 
m) over the myocyte
(in 20 ms). One of the pipettes was continuously perfused with
relaxing solution and the other with rigor solution (relaxing so-
lution without ATP and creatine phosphokinase and additional
K-propionate to adjust ionic strength to 180 mM). Thus, the cell
bathed in relaxing solution could be perfused with rigor solution
within 
 
 
 
20 ms, and vice versa.
SL was measured by a commercially available SL detection sys-
tem (IonOptix Corp.) (Helmes et al., 2003). The cell image was
digitized at a sampling speed of 240 Hz and displayed on a com-
puter screen. A user deﬁned region of interest was selected within
the myocyte (
 
 
 
30% of the cell surface area) and the video lines
within this region were averaged vertically, followed by a fast-Fou-
rier transformation. The ﬁrst-order peak in the spectrum was con-
verted to SL with a spatial resolution of 
 
 
 
5 nm per sarcomere.
At the onset of the experiment, the cell was in relaxing solu-
tion and had an SL of 
 
 
 
1.90 
 
 
 
m. Ca
 
2
 
 
 
-independent activation
was induced in the myocyte by switching relaxing solution to
ATP-free rigor solution (Helmes et al., 2003). Then, rigor solu-
tion was switched back to relaxing solution, allowing for a rapid
relengthening of the myocyte back to the slack SL (
 
 
 
1.90 
 
 
 
m).
Because of the close relationship between the maximum acceler-
ation (dSL·dt
 
 
 
2
max
 
) and maximum velocity of sarcomere re-
lengthening (dSL·dt
 
 
 
1
max
 
) when plotted against minimal SL
(SL
 
min
 
) attained during rigor contraction (Helmes et al., 2003),
we used in the present study dSL·dt
 
 
 
1
max
 
 as an index of restoring
force (dSL·dt
 
 
 
1
max
 
 is less sensitive to noise and is therefore pre-
ferred). Each myocyte was subjected to multiple rigor contrac-
tions to various SLs (down to SL 
 
 
 
 1.65 
 
 
 
m) and dSL·dt
 
 
 
1
max
 
 was
plotted against SL
 
min
 
. The obtained relation was ﬁtted with a lin-
ear line with R
 
2
 
 usually 
 
 
 
0.95. Experiments were conducted at
room temperature (22
 
 
 
C).
 
Intact Muscle
 
Thin trabeculae (diameter 
 
 
 
 250 
 
 
 
m) were dissected from the
right ventricle of the rat and experiments were performed ac-
cording to previous reports (ter Keurs et al., 1980; Kentish et al.,
1986; Stuyvers et al., 2002). We used a modiﬁed Tyrode solution
(130 mM NaCl, 1.2 mM MgCl
 
2
 
, 5 mM [15 mM for dissection] KCl,
2.8 mM sodium acetate, 10 mM HEPES, 10 mM glucose, 1.0 mM
CaCl
 
2
 
, 10 U/ml insulin, pH 7.4, 25
 
 
 
C) bubbled with 95% O
 
2
 
–5%
CO
 
2
 
. We also added 10 
 
 
 
M EGTA to the Tyrode solution to in-
hibit oxidation of catecholamines catalyzed by heavy metal ions
(Layland and Kentish, 2002). The muscle was stimulated with a
square pulse at 1.3-fold threshold with 5 ms duration at 0.5 Hz.
We measured SL during diastole by laser diffraction and initially
set it at 
 
 
 
1.90 
 
 
 
m, the length at which no detectable diastolic
force was developed (Kentish et al., 1986). We increased SL in a
stepwise manner (seven steps up to SL 
 
 
 
2.20 
 
 
 
m; each step in
200 ms), followed by a release of SL to the original 
 
 
 
1.90 
 
 
 
m. We
added 1 
 
 
 
M isoprenaline 5 min after the protocol was completed
(the time at which developed force recovers to the original value;
see Fig. 7 A). The same stretch protocol was repeated 10 min after
the isoprenaline application. At each SL, developed and diastolic
force of the fourth twitch was used for analysis (diastolic force was
averaged before and after this twitch). Preparations that devel-
oped spontaneous oscillations were excluded from analysis.
 
Gel Electrophoresis and Autoradiography
 
Skinned myocardial preparations prepared as described above
were incubated for 50 min at 22
 
 
 
C in relaxing solution containing
1000 cpm/pmol [
 
 
 
-
 
32
 
P]ATP (ICN Biomedicals, Inc.) with 1 U/
 
 
 
l
of puriﬁed PKA (Yamasaki et al., 2002). The preparations were
then solubilized and electrophoresed on 1.8–6% acrylamide gra-
dient gels, stained with Coomasie brilliant blue (CBB), destained,
dried, and exposed for 24 h to the autoradiographic ﬁlm at 22
 
 
 
C.
Phosphorylation was determined by phosphoscanner (Cyclone;
Packard Instrument Company). The CBB-stained gel and autora-
diograph were scanned, and the integrated optical density (OD)
of N2B and N2BA titins was determined (Yamasaki et al., 2002).
In another set of experiments, intact rat ventricular trabeculae,
prepared as described above, were continuously perfused for 10
min with the modiﬁed Tyrode solution (for composition see
above) bubbled with 95% O
 
2
 
–5% CO
 
2
 
, containing either 1 
 
 
 
M iso-
prenaline (to enhance phosphorylation of myoﬁbrillar proteins)
or 10 
 
 
 
M propranolol and 10 
 
 
 
M carbamyl choline (to enhance
dephosphorylation of myoﬁbrillar proteins). Then, the prepara-
tions were skinned for 2 h and incubated for 50 min at 22
 
 
 
C in re-
laxing solution containing 1000 cpm/pmol [
 
 
 
-
 
32
 
P]ATP with 1
U/
 
 
 
l of puriﬁed PKA. The preparations were then solubilized
and electrophoresed on 2–7% acrylamide gradient gels and auto-
graphs were obtained accordingly. Samples were electrophoresed
on the gel with four different loadings, and integrated OD-loading
relations were obtained (slope obtained from regression analysis;
see Yamasaki et al., 2002). The slope ratio obtained from CBB-
stained gels reﬂects differences in the relative protein concentra-
tions of the two groups and was used to correct the slope ratios of
corresponding autoradiographs (compare Yamasaki et al., 2002).
 
Statistical Analysis
 
Signiﬁcant differences were assigned using the paired or un-
paired Student’s 
 
t
 
 test as appropriate. Regression analysis was
performed using the least-square method. All data are expressed
as mean 
 
  
 
SEM, with 
 
n
 
 representing the number of muscles. Sta-
tistical signiﬁcance was veriﬁed at P 
 
  
 
0.05.
 
RESULTS
 
PKA Phosphorylates N2B and N2BA Titins
 
Fig. 1 shows CBB-stained gels of titin and autoradio-
graphs for RV, bovine left ventricular (BLV), and bo-
vine left atrial (BLA) muscles. As is well known, titin
consists of T1 and T2, the full-length protein and a
large degradation product, respectively, and T1 of N2BA
titin migrates slower than that of N2B titin. Consistent
with previous studies (e.g., Cazorla et al., 2000), the ra-
tio of N2B to N2BA titin is highest in RV, lowest in BLA
and intermediate in BLV. Radiographs (exposure 24 h)
revealed phosphorylation of both N2B and N2BA iso-
forms (Fig. 1 A). Densitometric analyses (Fig. 1 B) re-
vealed that T1 peaks of both N2B and N2BA titins over-
lap with the corresponding phosphorylated bands in
the autoradiograph, but not for T2, leading us to con-
clude that PKA phosphorylates both cardiac titin iso-
forms but not their T2 degradation products.
 
PKA Decreases Passive Force in Cardiac Muscle with Different 
Titin Expression Proﬁles
 
Fig. 2 A is a typical chart trace showing stress-relaxation
of a skinned RV preparation before and after PKA treat-
ment (SL increased from 1.9 to 2.25 
 
 
 
m). It is clearly
seen that passive force, both total and titin-based, is re- 
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duced following incubation with PKA. Fig. 2 B summa-
rizes the effect of PKA on titin-based passive force from
six to eight preparations for RV, BLV, and BLA (SL in-
creased from 1.9 to 2.25 
 
 
 
m). As reported previously
(Cazorla et al., 2000; Wu et al., 2000; Fukuda et al.,
2003), because of differential expressions of titin (com-
pare Fig. 1), passive force was highest in RV, intermedi-
ate in BLV, and lowest in BLA. PKA signiﬁcantly de-
creased passive force in all types of muscle, and the mag-
nitude of force decrease (both peak and steady-state
force) was greatest in RV, smallest in BLA, and interme-
diate in BLV. The PKA-induced decreases in passive force
are relatively small in BLV and especially in BLA, but
changes are statistically signiﬁcant. Therefore, PKA de-
creases passive force in cardiac muscle regardless of the
expression proﬁle of titin, and its effect is more pro-
nounced when N2B expression levels are high. PKI in-
hibited PKA-induced decreases in passive force in RV
(Fig. 2 B, inset) and also in BLV and BLA (not depicted).
To quantify PKA-induced changes in stress-relaxa-
tion, we ﬁtted the stress-relaxation data to three expo-
nential decays of the type y 
 
 
 
 y0 
 
 
 
 A1exp(
 
 
 
x/t1) 
 
 
 
A2exp( x/t2)   A3exp( x/t3), where y0 is the offset,
A1, A2, and A3 are decay amplitudes, and t1, t2, and t3
are decay time constants (compare Kulke et al., 2001).
The fact that stress-relaxation can be ﬁtted well with a
three-order exponential decay function suggests the ex-
istence of multiple sources of titin-based viscoelasticity
(Trombitas et al., 2003). The ﬁtting revealed that offset,
decay amplitudes, and decay time constants were signif-
icantly decreased and that changes in the amplitudes,
as well as in time constants, were greatest for the fastest
component (Fig. 2 C; Table I). These ﬁndings suggest
that PKA affects titin’s elasticity (y0) as well as viscoelas-
ticiy (decay amplitudes and time constants) (see dis-
cussion). Changes in these parameters were greatest
in RV, followed respectively by BLV and BLA.
It has been reported that large mammals have rela-
tively long end-diastolic SL ( 2.40  m, Rodriguez et
al., 1992) compared with small rodents ( 2.20   m,
Grimm et al., 1980; MacKenna et al., 1994). To ascer-
tain whether PKA affects passive force and stress-relax-
Figure 1. Titin phosphorylation in various muscle types. (A) Top, CBB-stained gel of solubilized RV, BLV, and BLA preparations
incubated with [ -32P]ATP in the presence of PKA; bottom, 24-h autoradiographic exposure. Note phosphorylation of T1 of N2B and
N2BA titins and no phosphorylation of T2. (B) Side-by-side comparison of gel and autoradiograph and densitometric scan of gel (blue)
and autoradiograph (red) for RV, BLV, and BLA.261 Fukuda et al.
ation at the upper limit of the physiological SL range of
large mammals where maximal levels of passive force
are generated (Wu et al., 2000), we conducted stress-
relaxation experiments at SL 2.40  m on BLV and BLA.
As shown in Fig. 3 A, titin-based passive force was ap-
proximately twofold higher than that at SL 2.25  m in
these preparations. Passive force was decreased by PKA
throughout the course of stress-relaxation, and the ef-
Figure 2. Effect of PKA on passive force in various types of skinned cardiac muscle. (A) Typical chart recording showing the effect of
PKA on total and titin-based passive force in RV. SL was increased from 1.90 to 2.25  m as indicated. Black, before PKA; red, after PKA.
Titin-based passive force was obtained by subtracting collagen-based passive force from total passive force. Arrows indicate the onset and
end of stress-relaxation. (B) Effect of PKA on titin-based passive force in RV, BLV, and BLA. SL was increased from 1.90 to 2.25  m. The
values of maximal Ca2 -activated force before PKA treatment were 51.52   8.53, 26.08   2.56, and 18.42   1.63 mN/mm2 in RV, BLV, and
BLA, respectively (at SL 1.90  m). Data obtained from each preparation (see A for example) were ﬁtted to three exponential decays as
described in text, and curves with mean values of exponential parameters are shown (compare Table I). RV, n   6; BLV, n   6; BLA, n  
8. Inset, effect of PKA PKI on titin-based passive force in RV preparations (SL increased from 1.90 to 2.25  m; n   6). PKA PKI does not
signiﬁcantly affect passive force. (C) Summary of stress-relaxation measurements. Percent changes compared with pre-PKA values (offsets,
amplitudes, and time constants) are shown. *, P   0.05 compared with pre-PKA values.262 Titin Phosphorylation and Myocardial Passive Stiffness
fect was signiﬁcant for both BLV and BLA. As found at
SL 2.25  m, ﬁtting the data to three exponential decays
revealed that (a) offset, decay amplitudes, and the fast-
est decay time constant (t1) were all decreased, and (b)
changes in the amplitudes were greatest for the fastest
component (Fig. 3 B; Table I). Again, PKA accelerates
stress-relaxation of passive cardiac muscle.
To more fully investigate the SL dependencies of the
PKA effect on passive force in preparations that express
different isoforms of titin, we performed stress-relax-
ation experiments at the shorter range of SLs (i.e., 2.10
and 2.20  m) and obtained relationships of SL vs. per-
cent reduction of passive force for peak and steady-
state passive force (Fig. 4). We found that in all muscle
types, PKA decreased passive force more markedly at
the short SL range than at the long SL range and that
the effect was inversely correlated with SL for peak
as well as for steady-state total and titin-based passive
force. Thus, the PKA effect on passive force is SL
dependent as the effect is more pronounced at the
shorter SL range. We clearly see that the PKA-induced
reduction in passive force (both total and titin-based) is
in the following order for peak as well as for steady-
state passive force (SL   2.25  m): RV   BLV   BLA.
We also found that the magnitude of the SL depen-
dence, as judged by the slope of the regression line,
varies depending on the expression proﬁle of titin, and
it is highest in RV (N2B titin dominant) and lowest in
TABLE I
Stress-relaxation Values Obtained before PKA Treatment
y0 A1 t1 A2 t2 A3 t3
mN/mm2 mN/mm2 s mN/mm2 min mN/mm2 min
Fig. 2
RV 7.72   0.99 4.15   0.59 0.87   0.06 3.49   0.33 0.42   0.08 3.87   0.43 5.95   0.88
BLV 4.00   0.54 2.03   0.38 1.15   0.08 1.95   0.31 0.50   0.03 1.75   0.26 5.59   0.28
BLA 2.40   0.24 1.20   0.16 1.16   0.11 1.21   0.16 0.51   0.09 0.99   0.15 5.97   0.81
Fig. 3
BLV 6.40   0.29 4.61   0.36 1.12   0.15 4.22   0.32 0.52   0.09 2.94   0.23 6.79   0.98
BLA 3.97   0.30 2.46   0.28 1.24   0.07 2.56   0.33 0.63   0.11 1.59   0.14 7.48   0.78
Fig. 5
RV 7.19   0.71 2.66   0.22a 0.64   0.10 2.53   0.18a 0.27   0.09 3.01   0.30 5.29   1.14
aP   0.05 compared with the corresponding values obtained with no gelsolin treatment (from Fig. 2).
Figure 3. Effect of PKA on passive force at the upper limit of the
physiological SL range in BLV and BLA. (A) Titin-based passive
force before and after PKA treatment in BLV and BLA. SL was
increased from 1.90 to 2.40  m. The values of maximal Ca2 -
activated force before PKA treatment were 27.49   2.93 and 19.48  
1.62 mN/mm2 in BLV and BLA, respectively (at SL 1.90  m). Data
ﬁtted to three exponential decays (compare Table I). BLV, n   8;
BLA, n   8. (B) Summary of stress-relaxation measurements. *,
P   0.05 compared with pre-PKA values.263 Fukuda et al.
BLA (N2BA titin dominant). This suggests that the SL
dependence of the PKA effect is greater in N2B titin
than in N2BA titin.
Effect of PKA on Passive Force in Gelsolin-treated 
Cardiac Muscle
To clarify whether the PKA-induced reduction in pas-
sive force results from an altered thin ﬁlament–titin in-
teraction or is solely titin based, we treated RV prepara-
tions with gelsolin to extract thin ﬁlaments (maximal
Ca2 -activated force,  5% of the control value) and ex-
amined the effect of PKA on passive force in these
preparations. Fig. 5 A is a typical chart record showing
stress-relaxation of gelsolin-treated RV before and after
PKA treatment. It has been reported that actin removal
with gelsolin almost completely abolishes stress-relax-
ation in experiments on rat cardiac myoﬁbrils (Kulke
et al., 2001). In the present study, however, gelsolin
treatment depressed peak passive force but did not
completely abolish stress-relaxation. Data from six mus-
cles (Fig. 5 B) showed that under the control condition
before PKA treatment, the value of peak titin-based pas-
Figure 4. SL dependence of the effect of PKA on passive force. Percent reduction is shown. (A) SL dependence for peak force. Data
ﬁtted to linear regression line. Left, total passive force. The slopes are  55.10 (R2   0.98; P   0.05),  14.56 (R2   0.97; P   0.01), and
 6.65 (R2   0.98; P   0.005), for RV, BLV, and BLA, respectively. Right, titin-based passive force. The slopes are  92.20 (R2   0.99; P  
0.05),  12.49 (R2   0.91; P   0.05), and  4.25 (R2   0.94; P   0.05), for RV, BLV, and BLA, respectively. (B) SL dependence for steady-
state passive force (data obtained 30 min after stretch). Left, total passive force. The slopes are  38.61 (R2   0.98; P   0.01),  6.69 (R2  
0.97; P   0.05), and  5.58 (R2   0.89; P   0.05), for RV, BLV, and BLA, respectively. Right, titin-based passive force. The slopes are  30.64
(R2   0.99; P   0.05),  5.10 (R2   0.89; P   0.05), and  3.29 (R2   0.92; P   0.05), for RV, BLV, and BLA, respectively. *, P   0.05
compared with BLA; #, P   0.05 compared with BLV. n   6–8.264 Titin Phosphorylation and Myocardial Passive Stiffness
sive force was signiﬁcantly smaller when compared with
that obtained with control preparations in Fig. 2 B (P  
0.05). However, the value of steady-state passive force
was not signiﬁcantly affected by gelsolin treatment
(P   0.05). Also, ﬁtting stress-relaxation with a three-
order exponential decay revealed that gelsolin treat-
ment decreases amplitudes with no signiﬁcant effect on
time constants (Table I).
PKA signiﬁcantly decreased passive force throughout
the course of stress-relaxation (Fig. 5 B). Importantly,
the magnitude of force reduction was similar to what
was found for control preparations in Fig. 2 B (Fig. 5 C).
Exponential analysis revealed a signiﬁcant reduction in
various parameters similar to those found for control
preparations (Fig. 5 D; compare Fig. 2 C). As in con-
trol preparations with no gelsolin treatment, signiﬁcant
changes in passive force were not found throughout
stress-relaxation with PKA PKI (unpublished data). It
is therefore likely that the PKA-induced decrease in pas-
sive force, as well as the PKA-induced acceleration of
Figure 5. Effect of PKA on passive force in gelsolin-
treated RV preparations. (A) Typical chart recording
showing the effect of PKA on total and titin-based
passive force. SL was increased from 1.90 to 2.25  m
as indicated. Black, before PKA; red, after PKA. Titin-
based passive force was obtained by subtracting
collagen-based passive force from total passive force.
Arrows indicate the onset and end of stress-relaxation.
(B) Summarized data from six preparations showing
the effect of PKA on titin-based passive force. SL was
increased from 1.90 to 2.25  m. The value of
maximal Ca2 -activated force before PKA treatment
was 3.12   1.38 mN/mm2 (at SL 1.90  m). Data ﬁtted
to three exponential decays (compare Table I). (C)
Bar graph comparing the PKA-induced decreases in
passive force in control (C; data taken from Fig. 2 B)
and gelsolin-treated preparations (G). No signiﬁcant
differences were observed (NS). (D) Summary of
stress-relaxation measurements. *, P   0.05 compared
with pre-PKA values.265 Fukuda et al.
stress-relaxation, is not due to altered titin–thin ﬁla-
ment interaction but instead is purely titin based.
Effect of PKA on Restoring Force
Titin produces not only passive force but also restoring
force at SLs where myocytes are shortened to below the
slack SL (Helmes et al., 1996, 2003). We investigated
the effect of PKA on skinned rat ventricular myocytes
that had been shortened to below their slack length
(using rigor contractions), followed by relaxation and
measurement of the relengthening velocity (dSL.dt 1
max)
as an index of restoring force.
Fig. 6 compares the typical data of the relationship of
dSL.dt 1
max vs. SLmin for control and PKA-treated myo-
cytes (obtained from the same heart). The relationship
was linear for both control and PKA-treated myocytes
(R2   0.95) at the SL range of  1.90 to  1.65  m, and
the slope of the relationship was signiﬁcantly less for the
PKA-treated myocyte (i.e., lower relengthening veloc-
ity). The inset summarizes the slope of the dSL.dt 1
max
vs. SLmin relationship for control and PKA-treated myo-
cytes with the value  20% less in the PKA-treated group
compared with the control group (P   0.05).
Effect of  -Adrenergic Stimulation on Diastolic Properties of 
Intact Muscle
We investigated whether diastolic force is decreased
upon  -adrenergic stimulation in stimulated intact rat
ventricular trabeculae. In this series of experiments, we
increased SL in seven steps (completed in 200 ms) and
measured diastolic force for the fourth twitch (diastolic
force averaged before and after the twitch), the time af-
ter which the decline in diastolic force was small (i.e.,
decline in diastolic force   10%). Thus, the diastolic
force measured in the present study mainly reﬂects
elasticity of living trabeculae (see discussion). Fig. 7 A
(top) illustrates the effect of 1  M isoprenaline on
twitch contractions at the slack SL. As is well known, de-
veloped force is increased and twitch duration is short-
ened with isoprenaline. Developed force increased in
response to the addition of isoprenaline, reached its
plateau in  2 min, and then remained stable (compare
de Tombe and ter Keurs, 1991). Fig. 7 A (middle and
bottom) shows a typical chart trace for the SL depen-
dence of the effect of isoprenaline on twitch contrac-
tions (same preparation used throughout experiment
shown in Fig. 7 A). It is clearly seen that developed
force is increased at each step after isoprenaline appli-
cation, while diastolic force is decreased. Note that with
(Fig. 7 A, middle right) and without isoprenaline (Fig.
7 A, middle left as control), developed force recovers to
the original level in  2 min upon release of muscle
length.
Fig. 7 B summarizes the results from six preparations
before and after isoprenaline application. Because de-
veloped force increased linearly in response to an in-
crease in SL above  1.90  m, the data were ﬁtted to a
linear regression line. The slope of the linear regres-
sion line increased by  1.6-fold in isoprenaline (P  
0.05), indicating that the Frank-Starling mechanism is
enhanced upon  -adrenergic stimulation, as reported
for ferret ventricular muscle by Komukai and Kurihara
(1997). Consistent with previous ﬁndings by others on
intact rat ventricular trabeculae (van Heuningen et al.,
1982; Kentish et al., 1986), diastolic force was nearly
zero at SL  1.90  m and increased rapidly as SL was in-
creased to  2.20  m. Here, to minimize the likelihood
of spontaneous oscillations that frequently occurred
upon isoprenaline application when SL was elongated
to  2.25  m and that could potentially affect diastolic
properties, we stretched preparations up to SL  2.20
 m (shorter than in skinned muscle experiments) in
all preparations. According to a previous report on in-
tact muscle (Stuyvers et al., 2002), diastolic force data
from each preparation were analyzed with an expo-
nential function, i.e., diastolic force   exp (k*(SL  
SL0))   1, where k is the exponent of diastolic stiffness
in mN/mm2 and SL0 is the intercept on the SL axis, i.e.,
the zero load SL. We found that isoprenaline reduced
diastolic force to a degree similar to what PKA did in
skinned RV preparations (i.e.,  20% at SL  2.20  m;
compare Fig. 4) with no signiﬁcant changes in SL0
(1.92   0.02 and 1.93   0.02  m, respectively, before
Figure 6. Effect of PKA treatment on relengthening velocity of
skinned rat ventricular myocytes following rigor contraction to
below the slack length. Examples of the relationship between
maximum relengthening velocity (dSL.dt 1
max) and the minimum
SL (SLmin) in control (black) and PKA-treated myocytes (red). The
relationship of dSL.dt 1
max vs. SLmin is ﬁtted well with a linear
regression line (R2   0.95). Inset, bar graph showing slopes of
dSL.dt 1
max vs. SLmin relationship of 93 control myocytes (from 12
animals) and 71 PKA-treated myocytes (from 10 animals). C,
control (no PKA). *, P   0.05 compared with control.266 Titin Phosphorylation and Myocardial Passive Stiffness
Figure 7. Effect of  -adrenergic stimula-
tion on systolic and diastolic properties of
intact RV preparations. (A) Typical chart
recording showing the effect of 1  M
isoprenaline (ISO). Top, effect of isopren-
aline on twitch contractions at the slack SL
( 1.90  m). Middle, twitch contractions at
different lengths before (left) and after
(right) isoprenaline. For this preparation,
SL was varied from 1.904 to 2.205  m and
from 1.902 to 2.201  m before and after
isoprenaline, respectively. Bottom, changes
in diastolic force are shown on a larger
scale. Diastolic force is decreased by isopren-
aline (arrows indicate diastolic force for
the last three stretches). (B) Top, the effect
of isoprenaline on developed force. Data
from each preparation were ﬁtted by a
linear regression line (for each set of data,
R     0.97; P     0.0001). Developed force
was increased with isoprenaline, especially
at the long SL range, and, consequently,
the slope of the linear regression line was
signiﬁcantly increased (P   0.05). Before
isoprenaline: y   167.85x   312.05. After
isoprenaline: y   270.70x   505.93. Bot-
tom, the effect of isoprenaline on diastolic
force. Data ﬁtted to an exponential func-
tion as described in text. The values at the
longest SL (seventh step in the protocol)
are as follows. Developed force, 56.84  
4.98 and 82.97   8.97 mN/mm2 (P   
0.05), before and after isoprenaline, re-
spectively. Diastolic force, 7.93   1.26 and
6.22   1.11 mN/mm2 (P   0.05), before
and after isoprenaline, respectively. SL,
2.17   0.01 before and after isoprenaline.
n   6. (C) Data showing reproducibility
of developed and diastolic force without
isoprenaline. Top, developed force. First
protocol: y   124.89x   219.14. Second
protocol: y   125.89x   223.75. Slopes are
not signiﬁcantly different. Bottom, diastolic
force. k: 8.18   0.65 and 8.21   0.89, re-
spectively, in the ﬁrst and second protocols
(P   0.05). SL0: 1.88   0.02 and 1.88  
0.03   m, respectively, in the ﬁrst and
second protocols (P   0.05). Neither pa-
rameter is signiﬁcantly different between
ﬁrst and second protocols. The values at the
longest SL (seventh step in the protocol)
are as follows. Developed force, 49.28  
4.89 and 47.63   5.05 mN/mm2 (P   
0.05), in the ﬁrst and second protocols,
respectively. Diastolic force, 7.84   0.60
and 7.87   0.48 mN/mm2 (P   0.05), in
the ﬁrst and second protocols, respectively.
SL, 2.16   0.01 for ﬁrst and second proto-
cols. n   6.267 Fukuda et al.
and after isoprenanline; P    0.05) and that it de-
creased the k value (8.99   1.29 and 8.14   1.24, re-
spectively, before and after isoprenaline; P    0.05).
There was a trend for SL dependence in the effect of
isoprenaline on diastolic force (i.e., greater effect at
shorter SLs), but this was not statistically signiﬁcant.
Control experiments without isoprenaline showed
that developed force and diastolic force were consistent
in the ﬁrst and second stretch protocol (Fig. 7 C), mak-
ing it unlikely that decreases in diastolic force via
 -adrenergic stimulation result from rundown of myo-
cardial diastolic properties. We therefore conclude that
 -adrenergic stimulation decreases diastolic force of
stimulated cardiac muscle.
 -Adrenergic Stimulation-dependent Titin Phosphorylation in 
Intact Cardiac Muscle
Fig. 8 shows 32P incorporation by titin in skinned rat
ventricular trabeculae, after 10 min perfusion of intact
trabeculae with either 10  M propranolol and 10  M
carbamyl choline or 1  M isoprenaline, skinning, and
performing back phosphorylation assays (see materi-
als and methods). We also included a study of myo-
sin-binding protein C (MyBP-C) for comparative rea-
sons. Results show that at similar quantities of loaded
protein, isoprenaline-treated preparations incorporate
less 32P in both titin and MyBP-C (Fig. 8 A). Note no
phosphorylation for T2, as in Fig. 1.
The mean results of ﬁve experiments are shown in
Fig. 8 B. The differences in 32P incorporation in pro-
pranolol (plus carbamyl choline) and isoprenaline-
treated preparations were statistically signiﬁcant for
both titin (74.7   8.5%) and My-BPC (69.8   6.4%) at
P   0.01. These differences in 32P incorporation are
similar to those obtained in our previous study with
ventricular myocytes of the rat (Yamasaki et al., 2002).
These results support the notion that in intact muscle,
titin is phosphorylated by PKA in response to  -adren-
ergic stimulation.
DISCUSSION
 -Adrenergic stimulation results in marked changes in
the contractile behavior of the heart. This includes in-
creased rates of rise and fall of developed pressure and
an increased heart rate. The heart’s systolic and dia-
stolic functions are interrelated, and the positive chro-
notropic effects are likely to necessitate adjustments of
diastolic properties. In the present study, we found that
myocardial compliance is increased upon  -adrenergic
stimulation and that the effect is titin isoform depen-
dent (i.e., greater in muscles that express N2B titin at
higher levels). These ﬁndings reveal a novel function of
titin that allows for more rapid and complete cardiac
chamber ﬁlling during  -adrenergic stimulation.
Phosphorylation of Titin
Consistent with previous ﬁndings on rat cardiomyocytes
(Yamasaki et al., 2002), only T1, but not T2, was phos-
phorylated by PKA in skinned myocardial preparations
with different titin expression proﬁles (Fig. 1). Since T2
is a proteolytic cleavage product of titin that constitutes
largely the A-band region of the molecule, these ﬁnd-
ings are consistent with the notion that the phosphory-
lation site is located in the extensible I-band region of
titin. In previous work on human N2B titin using re-
combinant protein fragments that represent the various
spring elements (i.e., tandem Ig segments, PEVK seg-
Figure 8. Effect of propranolol and carbamyl choline (Pro) and
isoprenaline (ISO) on titin and MyBP-C phosphorylation by
using the back phosphorylation assay. Intact rat right ventricular
trabeculae were treated with Pro or ISO, followed by skinning and
incubation with [ -32P]ATP in the presence of PKA. (A) Gel and
corresponding autoradiograph for titin (top) and MyBP-C bands
(bottom). Each sample was electrophoresed with four different
loadings (two loadings are shown here). Integrated OD was
determined for each band and plotted against loading volume.
(B) Pro vs. ISO slope ratio determined from autoradiographs after
correction for protein loading differences between Pro and
ISO-treated samples. Results indicate signiﬁcantly less 32P incorpo-
ration after ISO treatment in titin as well as in MyBP-C.268 Titin Phosphorylation and Myocardial Passive Stiffness
ment, and N2B unique sequence), the N2B unique se-
quence was the only element that was phosphorylated
by PKA, and titin phosphorylation resulted in a reduc-
tion of passive force in response to ramp stretch (Ya-
masaki et al., 2002). Since the N2B element is present in
both N2B and N2BA isoforms, it is reasonable to pro-
pose that phosphorylation of the N2B unique sequence
occurs in both N2B and N2BA titins. However, consider-
ing that the extensible region of N2BA titin includes ad-
ditional sequences not present in the N2B isoform
(such as additional PEVK sequences and unique se-
quences in the N2A element; Granzier and Labeit,
2002) and that there is variation in the sequence of the
N2B element of different animal species (Greaser et al.,
2002), this proposal requires future testing.
Effect of PKA-based Phosphorylation on Passive and 
Restoring Forces
At physiological SLs above the slack SL, both titin and
collagen contribute to passive force of cardiac muscle,
with collagen’s role more dominant at long SLs (Gran-
zier and Irving, 1995). The present study revealed that
titin-based passive force is decreased by PKA and that
the effect is large enough to result in a reduction of to-
tal passive force at all SLs (Fig. 4).
It has been reported that titin interacts with thin ﬁla-
ments and that this interaction provides a source of vis-
cosity in cardiac muscle (Kulke et al., 2001; Yamasaki et
al., 2001). It would therefore be possible that PKA-
induced phosphorylation of TnI impacts the thin ﬁla-
ment–titin interaction and possibly decreases passive
force upon stretch. To investigate this possibility, we
used gelsolin to extract thin ﬁlaments. Peak passive
force and amplitudes of the three exponential decays
(A1 and A2) were signiﬁcantly smaller after thin ﬁla-
ment extraction with no signiﬁcant changes in steady-
state passive force (see results and Table I). The ﬁnd-
ing that in thin ﬁlament–extracted preparations, PKA
signiﬁcantly decreased passive force throughout the
course of stress-relaxation, to a magnitude similar to
that observed in control preparations (Fig. 5 C), indi-
cates that the PKA effect does not involve titin–thin ﬁla-
ment interaction but is solely titin based.
Passive force reduction due to PKA-dependent phos-
phorylation might be explained by assuming that phos-
phorylation destabilizes native structures within titin,
possibly formed by the N2B unique sequence, resulting
in contour length gain and an ensuing reduction in
fractional extension of titin’s extensible region. Fur-
thermore, since some of these structures might have a
low stability and exist mainly at short SLs (Yamasaki et
al., 2002), phosphorylation is expected to have the
greatest effect at short SLs (i.e., greater passive reduc-
tion at shorter SLs), consistent with the ﬁndings of the
present work (Fig. 4). In previous work on cardiac myo-
cytes, we showed that for native conformations within
titin to recover from effects of stretch, a prolonged pe-
riod of rest (  200 s) at the slack SL is required
(Helmes et al., 1999). Because the work on intact prep-
arations (Fig. 7) did not impose such rest periods (in-
deed, due to internal shortening during the twitch con-
tractions, sarcomeres are undergoing continuous cy-
cles of shortening/lengthening), it is likely that native
structures of low stability are absent in these prepara-
tions, possibly explaining the absence of signiﬁcant SL
dependence in the effect of  -adrenergic stimulation
on diastolic force.
The present ﬁnding that passive force reduction is
less in muscles that have a lower N2B:N2BA ratio (BLA  
BLV   RV) indicates that the effect of phosphorylation
on force generated by N2BA titin is less than that of
N2B titin (SL   2.25  m). This is consistent with the
notion that the passive force reduction is due to a re-
duction in the fractional extension (end-to-end length
divided by contour length) of titin’s extensible region.
Because the N2BA isoform has a much longer PEVK
segment and contains an additional tandem Ig seg-
ment (Granzier and Labeit, 2002), its contour length is
longer than that of N2B titin, diminishing the effect of
the phosphorylation-induced contour length gain of
the N2B unique sequence on the fractional extension
of titin’s extensible region.
An interesting phenomenon observed in the present
study is that stress-relaxation is accelerated by PKA,
with the effect being most sensitive for the fastest com-
ponent (t1) and that, importantly, the accelerating ef-
fect was observed in thin ﬁlament–extracted prepara-
tions (Fig. 5 D). Therefore, the phosphorylation-sensi-
tive acceleration of stress-relaxation is a phenomenon
that resides in titin per se. It is worth noting that the
PEVK-thin ﬁlament interaction is not the only source
for viscosity of passive cardiac muscle and that the
unique N2B sequence is an additional source (Helmes
et al., 1999). Thus, PKA-induced changes in the native
structure of the N2B sequence might be responsible for
the acceleration of stress-relaxation.
We also studied the restoring force by inducing rigor
contraction followed by relaxation and using the maxi-
mal relengthening velocity as an index of restoring
force (compare Helmes et al., 2003). Restoring force
was reduced upon PKA treatment (Fig. 6), with the
magnitude of reduction similar to that observed for pas-
sive force (compare Fig. 4). This ﬁnding suggests that
PKA-based phosphorylation of titin reduces not only
passive force but also restoring force, with as possible
mechanism a phosphorylation-induced contour length
gain of the N2B unique sequence and resultant reduc-
tion of fractional extension of titin’s I-band region.
Recent studies suggest that titin plays a role in length-
dependent activation, possibly via interﬁlament lat-269 Fukuda et al.
tice  spacing modulation (for review see Fukuda and
Granzier, 2004). Currently, the effect of PKA on length-
dependent changes in Ca2  sensitivity is unsolved. Kaji-
wara et al. (2000) reported that PKA diminishes length-
dependent changes in Ca2  sensitivity of force, while
Konhilas et al. (2003) reported that length-dependent
changes in Ca2  sensitivity are either enhanced (when
[Ca2 ] was expressed on an absolute scale) or un-
changed (when pCa was used), in skinned rat ventricu-
lar muscle. Changes in length-dependent activation
and, possibly, deactivation (Helmes et al., 2003) of car-
diac muscle with PKA-based titin phosphorylation are
areas for future research.
Physiological Signiﬁcance
To address whether the results on skinned muscle are
physiologically relevant, we used a twitch protocol on
intact muscle. In these experiments, we measured dia-
stolic force at a time when the rate of decline in dia-
stolic force was small (see results) and, therefore, the
obtained values are likely to reﬂect mainly the passive
elasticity of living cardiac muscle (compare Chiu et al.,
1982). This explains why diastolic force at SL  2.20  m
(9.02   0.45 mN/mm2; Fig. 7 B, middle) is similar to
total passive force obtained in skinned RV preparations
at SL 2.20  m at the steady state (10.26   1.95 mN/
mm2, 30 min after stretch, n   6). This similarity also
indicates that the contribution of actomyosin interac-
tion to diastolic force is likely to be low or absent. This
conclusion is consistent with the work of Layland and
Kentish (2002) that showed that in rat ventricular tra-
beculae at low stimulation frequencies ( 0.75 Hz) and
a temperature of 25 C (as in the present study), acto-
myosin interaction does not contribute to diastolic
force. It is, thus, reasonable to assume that the diastolic
force under baseline conditions is solely due to passive
muscle force and that the decrease in diastolic force
with  -adrenergic stimulation (Fig. 7, A and B) is due
to a decrease in passive muscle force. In the present
study, we found that titin can be phosphorylated upon
 -adrenergic stimulation in intact rat ventricular tra-
beculae under the experimental condition used for the
twitch protocol (Fig. 8). Therefore, the present ﬁnd-
ings suggest that  -adrenergic stimulation phosphory-
lates titin and that this results in a decrease in diastolic
force in intact cardiac muscle. Reduced Ca2  sensitivity
of actomyosin-based force (e.g., Okazaki et al., 1990)
upon  -adrenergic stimulation, coupled possibly with
enhanced Ca2  dissociation from TnC due to TnI
phosphorylation (Robertson et al., 1982; Zhang et al.,
1995), may also result in a decrease in diastolic force,
especially at higher stimulation frequencies. The com-
parison of diastolic force with passive force (see above)
suggests, however, that the effect of titin phosphoryla-
tion might be dominant in the present study.
The positive chronotropic effect of  -adrenergic
stimulation could potentially cause incomplete ventric-
ular ﬁlling (due to the shortened diastolic interval),
and this might be compensated by multiple mecha-
nisms including increased venous return (e.g., Imai et
al., 1978; Leenen and Reeves, 1987). We propose that
one such mechanism is based on titin phosphorylation
that promotes ventricular ﬁlling via a reduction of ven-
tricular wall stiffness. Our ﬁnding that the effect of
phosphorylation on passive force is largest in tissues
that express high levels of N2B titin might reﬂect the
high beat frequency encountered in species (e.g., rat
and mouse) that express high levels of N2B titin (Ca-
zorla et al., 2000) and their short baseline diastolic in-
terval. Here, one may point out that titin produces re-
storing force in early diastole (the systolic–diastolic
transition) (Helmes et al., 1996), possibly to facilitate
rapid ventricular ﬁlling via deactivating myoﬁlaments
(Helmes et al., 2003), and, therefore, PKA-induced re-
duction in titin-based restoring force (Fig. 6) may tend
to delay myoﬁbrillar deactivation. This possible unben-
eﬁcial effect might be offset, however, at the cardiac
muscle level via acceleration of myocardial relaxation
due to PKA-based phosphorylation of phospholamban
and TnI (e.g., Bers, 2001, 2002) and reduction of ven-
tricular wall stiffness due to titin phosphorylation (Ya-
masaki et al., 2002 and present study). Clearly, more
work is required to fully understand the effect of titin
phosphorylation on the ﬁlling of the heart.
To our knowledge, a consensus has not been achieved
regarding the effect of  -adrenergic stimulation on dia-
stolic pressure at the isolated heart level. For example,
Layland et al. (2004) and Grieve et al. (2004) reported
no effect in mouse, whereas van Kerckhoven et al.
(2000) observed dose-dependent decreases in diastolic
pressure in rat. The view that phosphorylation of titin
might improve ventricular ﬁlling is consistent, however,
with multiple studies that revealed that the diastolic
pressure–volume relationship falls upon  -adrenergic
stimulation in vivo (humans, Udelson et al., 1989; Parker
et al., 1991; Nagata et al., 1995; rats, Salyers et al., 1988).
The importance of the present study is further high-
lighted by the recent reports of changes in titin isoform
expression during heart failure (Neagoe et al., 2002;
Wu et al., 2002; Makarenko et al., 2004; Nagueh et al.,
2004), since our ﬁndings predict that the sensitivity of
diastolic pressure to  -adrenergic stimulation will vary
accordingly.
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